Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 02  •  04:00PM ET
15.90
Dollar change
0.00
Percentage change
0.00
%
Index
-
P/E
-
EPS (ttm)
-0.22
Insider Own
5.79%
Shs Outstand
12.10M
Perf Week
-
Market Cap
192.33M
Forward P/E
7.58
EPS next Y
2.10
Insider Trans
0.00%
Shs Float
11.40M
Perf Month
-5.07%
Enterprise Value
181.68M
PEG
-
EPS next Q
0.52
Inst Own
86.84%
Perf Quarter
-9.14%
Income
-2.53M
P/S
4.72
EPS this Y
47.67%
Inst Trans
-2.74%
Perf Half Y
10.03%
Sales
40.76M
P/B
0.82
EPS next Y
-2.88%
ROA
-0.84%
Perf YTD
-7.56%
Book/sh
19.44
P/C
4.50
EPS next 5Y
-
ROE
-0.97%
52W High
17.90 -11.19%
Perf Year
14.47%
Cash/sh
3.53
P/FCF
7.18
EPS past 3/5Y
- -
ROIC
-0.95%
52W Low
12.54 26.84%
Perf 3Y
12.42%
EV/EBITDA
7.80
Sales past 3/5Y
-0.47% 2.08%
Gross Margin
95.75%
Volatility
3.06% 1.94%
Perf 5Y
32.10%
EV/Sales
4.46
EPS Y/Y TTM
-118.37%
Oper. Margin
58.94%
ATR (14)
0.37
Perf 10Y
99.79%
Quick Ratio
9.41
Sales Y/Y TTM
-13.75%
Profit Margin
-6.21%
RSI (14)
33.41
Current Ratio
9.41
EPS Q/Q
-436.60%
SMA20
-5.40%
Beta
0.22
Debt/Eq
0.14
Sales Q/Q
-34.19%
SMA50
-6.24%
Rel Volume
0.00
Prev Close
15.90
Employees
9
LT Debt/Eq
0.14
SMA200
-0.89%
Avg Volume
10.06K
Price
15.90
IPO
Sep 22, 1999
Option/Short
No / No
Trades
Volume
0
Change
0.00%
Mar-13-26 08:30AM
Nov-07-25 12:14AM
Nov-06-25 05:10PM
Oct-09-25 06:00PM
Aug-16-25 03:04AM
05:15PM Loading…
Aug-14-25 05:15PM
Aug-07-25 07:30AM
Jul-31-25 08:30AM
Jul-17-25 07:29AM
Jul-15-25 05:00PM
May-15-25 04:30PM
May-09-25 07:30AM
Apr-10-25 04:15PM
Mar-20-25 01:45PM
Mar-19-25 09:20PM
09:10PM Loading…
09:10PM
Mar-13-25 07:30AM
Feb-07-25 11:00AM
Jan-06-25 07:35AM
Nov-14-24 04:15PM
Oct-17-24 04:15PM
Aug-15-24 08:15AM
Jul-17-24 04:15PM
Jul-08-24 05:00PM
May-19-24 08:08AM
May-15-24 10:54PM
04:05PM
Mar-23-24 05:33AM
Mar-21-24 01:53PM
07:00AM
04:05PM Loading…
Jan-23-24 04:05PM
Nov-09-23 07:30AM
Nov-06-23 04:05PM
Oct-30-23 08:00AM
Oct-18-23 08:00AM
Oct-11-23 08:00AM
Oct-03-23 04:05PM
Sep-28-23 06:34PM
Sep-26-23 04:07PM
Aug-17-23 09:00AM
Aug-09-23 04:05PM
Aug-08-23 08:00AM
Jul-27-23 05:43PM
Jul-17-23 04:05PM
Jun-28-23 04:05PM
May-11-23 09:00AM
07:00AM
May-02-23 04:36PM
Apr-03-23 07:30AM
Mar-31-23 08:00AM
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company offers capital and investments in life science companies, institutions, and inventors. It operates through the Finance Receivables and Pharmaceutical Development segments. The Finance Receivables segment is a healthcare capital provider which offers customized financing solutions to a broad range of life science companies, institutions, and investors. It is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Pharmaceutical Development segment strategy is to utilize the Peptelligence platform to create a wholly-owned portfolio of milestone and royalty income by out-licensing the technology. The company was founded in July 1996 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Staggs Joe David JRPRESIDENTApr 15 '25Option Exercise11.2233,750378,525149,623Apr 17 04:34 PM